CSIMarket
 


Tricida Inc   (TCDA)
Other Ticker:  
 
 

TCDA's Operating Income Growth by Quarter and Year

Tricida Inc 's Operating Income results by quarter and year




TCDA Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -45.87 -49.05 -58.12
III Quarter September -24.06 -35.69 -72.27 -45.10
II Quarter June -26.68 -29.33 -57.18 -37.84
I Quarter March -27.67 -42.07 -72.91 -37.78
FY   -78.41 -152.96 -251.41 -178.84



TCDA Operating Income third quarter 2022 Y/Y Growth Comment
Tricida Inc in the third quarter 2022 recorded Operating Loss of $ -24.06 millions.

According to the results reported in the third quarter 2022, Tricida Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Tricida Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2022.

Explain Operating Income growth


TCDA Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Tricida Inc 's third quarter 2022 Operating Income $ -24.06 millions TCDA's Income Statement
Tricida Inc 's third quarter 2021 Operating Income $ -35.69 millions Quarterly TCDA's Income Statement
New: More TCDA's historic Operating Income Growth >>


TCDA Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Tricida Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TCDA's III. Quarter Q/Q Operating Income Comment
Despite the fact, that Tricida Inc in the III. Quarter 2022 revealed Operating Loss of $ -24.06 millions, some analyst mentioned, that this show improvement compare to the -26.68 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Tricida Inc achieved highest sequential Operating Income growth. While Tricida Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TCDA's III. Quarter Q/Q Operating Income Comment
Even if Tricida Inc in the III. Quarter 2022 admitted Operating Loss of $ -24.06 millions, management point out, that this point to recovery in contrast to the -26.68 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Tricida Inc achieved highest sequential Operating Income growth. While Tricida Inc 's Operating Income growth quarter on quarter, overall rank is .


Tricida Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Operating Income 12 Months Ending $ -124.28 $ -135.91 $ -138.56 $ -152.95 $ -156.14
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Tricida Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Tricida Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
TCDA's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for TCDA's Competitors
Operating Income Growth for Tricida Inc 's Suppliers
Operating Income Growth for TCDA's Customers

You may also want to know
TCDA's Annual Growth Rates TCDA's Profitability Ratios TCDA's Asset Turnover Ratio TCDA's Dividend Growth
TCDA's Roe TCDA's Valuation Ratios TCDA's Financial Strength Ratios TCDA's Dividend Payout Ratio
TCDA's Roa TCDA's Inventory Turnover Ratio TCDA's Growth Rates TCDA's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2022
Zoetis Inc -0.28%$ -0.278 millions
Charles River Laboratories International inc -3.10%$ -3.098 millions
Sotera Health Company-3.77%$ -3.770 millions
Encompass Health Corporation-3.92%$ -3.919 millions
Abiomed Inc -4.04%$ -4.041 millions
Owens and Minor inc-4.18%$ -4.180 millions
Amphastar Pharmaceuticals Inc -6.22%$ -6.221 millions
Phibro Animal Health Corporation-6.35%$ -6.351 millions
Boston Scientific Corporation-7.49%$ -7.494 millions
Conmed Corporation-9.22%$ -9.221 millions
Intuitive Surgical Inc -9.87%$ -9.873 millions
Cadre Holdings Inc -10.60%$ -10.605 millions
Eli Lilly And Company-10.88%$ -10.881 millions
Bio techne Corp-10.92%$ -10.922 millions
Corcept Therapeutics Inc-11.86%$ -11.862 millions
U S Physical Therapy Inc-12.03%$ -12.030 millions
Universal Health Services Inc -12.37%$ -12.366 millions
Semler Scientific Inc -14.96%$ -14.963 millions
National Research Corporation-15.44%$ -15.444 millions
Lhc Group Inc -15.76%$ -15.758 millions
Merck and Co Inc -16.69%$ -16.694 millions
Zynex inc -18.49%$ -18.494 millions
Pediatrix Medical Group Inc -19.40%$ -19.400 millions
Molecular Templates inc -19.85%$ -19.852 millions
Kintara Therapeutics Inc -22.19%$ -22.191 millions
Tenax Therapeutics Inc -23.27%$ -23.270 millions
Alpha Pro Tech Ltd -23.79%$ -23.793 millions
Elite Pharmaceuticals Inc -24.00%$ -24.003 millions
Maravai Lifesciences Holdings Inc -25.48%$ -25.479 millions
Gilead Sciences Inc -26.16%$ -26.158 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com